683 Capital Management »

Insmed shares owned by 683 Capital Management

Quarter-by-quarter ownership of Insmed shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $35M 15M 2.29
2024-06-30 $22M 10M 2.12

More positions owned by 683 Capital Management

Eli Lilly & Co. Put Option (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Ero Copper Corp (ERO)
Hilton Grand Vacations (HGV)
Carvana Cl A (CVNA)
Insmed Note 0.750% 6/0 (Principal)
Wave Life Sciences SHS (WVE)
Alnylam Pharmaceuticals Put Option (ALNY)
Cogent Communications Hldgs Com New (CCOI)
Tg Therapeutics (TGTX)
BorgWarner (BWA)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Viking Therapeutics (VKTX)

View all positions for 683 Capital Management

Top funds holding Insmed

D. E. Shaw & Co
Whitebox Advisors
Baker Bros. Advisors
Henderson Group
Franklin Resources
CSS
Ing Investment Management
683 Capital Management
Calamos Advisors
State Street Corporation
Capstone Investment Advisors
DeepCurrents Investment Group
Lord, Abbett & Co
SSI Investment Management
Jpmorgan Chase & Co

View all funds holding Insmed